ProCE Banner Activity

PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Slideset Download
Download this slideset for expert insight on the latest evidence on PARP inhibition and novel PARP inhibitor combination therapy in advanced prostate cancer.

Released: April 12, 2021

Expiration: April 11, 2022

No longer available for credit.

Share

Faculty

Charles Ryan

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.